Serum Calprotectin (S100A8/A9) in Diagnosis, Monitoring, and Prognosis of Rheumatic Diseases

Watch now

Serum calprotectin plays a critical role in the pathogenesis of rheumatoid arthritis (RA), as it triggers chemotaxis, phagocyte migration, and modulation of neutrophils and macrophages. Calprotectin has been found to correlate with disease activity, and may add additional information to that provided by conventional biomarkers such as C-reactive protein (CRP).

This webinar provides an overview of the many options for use of serum calprotectin in adult and pediatric patients suffering from autoinflammatory diseases such as rheumatoid arthritis, Still’s disease, vasculitis, and juvenile idiopathic arthritis (JIA).

Key learning objectives

  • Discuss the role of calprotectin as a biomarker in pediatric rheumatic diseases
  • Explain the clinical applications of calprotectin in diagnosis, monitoring, and prognosis
  • Evaluate how serum calprotectin aids in the diagnosis, monitoring of disease activity, and differentiation between rheumatic diseases and other conditions, such as infections and fever of unknown origin

Who should attend?

Rheumatologists, pediatricians, immunologists, internal medicine, lab directors, and lab managers.

Accreditation statement

SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the ADLM. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@myadlm.org.

Certificate of attendance
A certificate of attendance is available for webinar viewers. To request yours, email editor@selectscience.net after viewing the webinar.

Webinar details

  • Cost: Free to attend
  • Location: Online
  • Duration: 60 minutes

Missed the live event?
Register now to access the full webinar and hear all the insights shared during the discussion.

Speakers

Prof. Dr. Marija Jeluŝić
Prof. Dr. Marija Jeluŝić
Professor of paediatrics and vice-chair, Department of Pediatrics at the University of Zagreb
See more

Moderator

Dora Wells
Dora Wells
Clinical Content Editor, SelectScience

What will this webinar cover?

Join the webinar to get answers to these questions:

  • How does serum calprotectin contribute to the pathogenesis of rheumatoid arthritis and other autoinflammatory diseases?
  • In what ways does calprotectin complement or improve upon conventional biomarkers like CRP?
  • How can calprotectin be used to diagnose and monitor pediatric rheumatic diseases such as JIA and Still’s disease?
  • How does serum calprotectin help differentiate rheumatic disease flares from infections or fever of unknown origin?
  • What are the practical clinical applications of calprotectin for prognosis and treatment decisions?

Links

Tags